Navigation Links


Calando in Medical Technology

Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on Targeted, Systemic Delivery of siRNA

PASADENA, Calif.--(BUSINESS WIRE)--Mar 20, 2007 - Arrowhead Research Corporation (NASDAQ:ARWR) announced today that majority-owned subsidiary Calando Pharmaceuticals has published results in the Proceedings of the National Academy of Sciences (PNAS) of the first non-human primate study to use multi...

Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate

PASADENA, Calif.--(BUSINESS WIRE)--Apr 3, 2007 - Arrowhead Research Corporation (NASDAQ: ARWR) announced the publication by its majority-owned subsidiary Calando Pharmaceuticals, Inc. of a study demonstrating the anti-proliferative effect of the siRNA sequence selected as the therapeutic component ...

Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting

Novel Systems May Provide Cancer Patients With Improved Potential to Battle Their Disease PASADENA, Calif., April 16, 2007 /PRNewswire-FirstCall/ -- Arrowhead Research Corporation announced today that two of its majority-owned subsidiaries, Insert Therapeutics Inc. and Calando Pharmaceuticals Inc....

Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal

...s to cause highly targeted gene silencing. About calando Pharmaceuticals Inc. calando Pharmaceuticals Inc. (www.calandopharma.com), a ma...with pharmaceutical and biotechnology companies. calando Technology Calando's cyclodextrin-containing pol...

Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate

...f Cancer Research (AACR). This paper describes how calando researchers and their collaborators determined the...Chief Executive Officer. Petrovich also noted that calando has filed for patent protection on several siRNA d...s to cause highly targeted gene silencing. About calando Pharmaceuticals Inc. ...

Calando Pharmaceuticals Announces Preclinical Efficacy and Safety Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting

...," said Jeremy Heidel, Chief Scientific Officer at calando Pharmaceuticals. "This formulation was well-tolera... cells has also been accomplished in vivo. About calando Pharmaceuticals Inc. calando Pharmaceuticals Inc. (Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
(Date:11/25/2009)...SON, WI, NOVEMBER 25, 2009 Soil is the linchpin o...d hydrosphere meet. Despite that, many students se... nothing more. Soil science educators are challeng...c recognize the critical importance of soil in the... science and earth science teachers at University ...
(Date:11/24/2009)...Lupus Research Institute (LRI) today named 12 new ....6 million, recognize innovative work across a bro...or their creativity, novelty, and potential to dri...at, and cure the complex disease of systemic lupus...ed lupus researchers across the nation and include...
(Date:11/24/2009)...nger and the American College of Medical Toxicolog...n the publication of the Journal of Medical Toxic...ginning in March 2010. It was previously publishe...e Journal of Medical Toxicology , an internationa...g the science and practice of medical toxicology. ...
Breaking Biology News(10 mins):It's not just dirt! 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2Blue Cross and Blue Shield of Florida Expands Low Cost BlueSelect Health Plan to Five Florida Counties 50873 1Blue Cross and Blue Shield of Florida Expands Low Cost BlueSelect Health Plan to Five Florida Counties 50873 2The American Academy of Pediatrics Names Lu Ann Papile M D FAAP as Chair of the Fetus and Newborn Committee 50871 1The American Academy of Pediatrics Names Lu Ann Papile M D FAAP as Chair of the Fetus and Newborn Committee 50871 2The American Academy of Pediatrics Names Lu Ann Papile M D FAAP as Chair of the Fetus and Newborn Committee 50871 3Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 1Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 2Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 3Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 4Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 5
Other Contentsfragilefragilefragilefragilefragilefrostbitefrontalfrontalfrontalfrontalfrontalfunnelfunnelfurniturefurniturefurniturefurniturefuruncle